Clinical Trial Update: Effect of Methylprednisolone on Systemic Inflammatory Response During Pediatric Congenital Open-Heart Surgery [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial investigates whether methylprednisolone reduces the systemic inflammatory response in pediatric patients undergoing congenital open-hea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Congenital Heart Disease
• Cyanotic Heart Disease

Drugs mentioned

• METHYLPREDNISOLONE (methylprednisolone)

Snippet

Sponsor: Aga Khan University | Conditions: Cyanotic Heart Disease, Cardiopulmonary Bypass | Phase 4 | Status: RECRUITING